Vanguard Group
ASTH icon

Vanguard Group’s Astrana Health ASTH Stock Holding History

Vanguard Group’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$105M Sell
4,238,192
-482,884
-10% -$12.8M ﹤0.01% 1851
2025
Q3 		$134M Sell
4,721,076
-112,308
-2% -$3.04M ﹤0.01% 1730
2025
Q2 		$120M Sell
4,833,384
-65,608
-1% -$1.85M ﹤0.01% 1746
2025
Q1 		$152M Buy
4,898,992
+213,033
+5% +$7.1M ﹤0.01% 1607
2024
Q4 		$148M Buy
4,685,959
+20,757
+0.4% +$986K ﹤0.01% 1678
2024
Q3 		$270M Sell
4,665,202
-52,885
-1% -$2.6M ﹤0.01% 1378
2024
Q2 		$191M Sell
4,718,087
-342,123
-7% -$13.6M ﹤0.01% 1515
2024
Q1 		$212M Buy
5,060,210
+10,282
+0.2% +$401K ﹤0.01% 1477
2023
Q4 		$193M Buy
5,049,928
+260,687
+5% +$8.68M ﹤0.01% 1523
2023
Q3 		$148M Buy
4,789,241
+43,714
+0.9% +$1.51M ﹤0.01% 1592
2023
Q2 		$150M Buy
4,745,527
+32,257
+0.7% +$1.11M ﹤0.01% 1623
2023
Q1 		$172M Buy
4,713,270
+274,315
+6% +$9.6M ﹤0.01% 1531
2022
Q4 		$131M Buy
4,438,955
+172,563
+4% +$5.55M ﹤0.01% 1649
2022
Q3 		$166M Buy
4,266,392
+66,735
+2% +$3.05M ﹤0.01% 1498
2022
Q2 		$162M Buy
4,199,657
+273,681
+7% +$10.4M ﹤0.01% 1557
2022
Q1 		$190M Buy
3,925,976
+28,661
+0.7% +$1.48M ﹤0.01% 1586
2021
Q4 		$286M Buy
3,897,315
+750,357
+24% +$61.6M 0.01% 1379
2021
Q3 		$287M Buy
3,146,958
+1,410,547
+81% +$120M 0.01% 1356
2021
Q2 		$109M Buy
1,736,411
+463,617
+36% +$17.1M ﹤0.01% 1957
2021
Q1 		$34.5M Buy
1,272,794
+19,007
+2% +$457K ﹤0.01% 2507
2020
Q4 		$22.9M Buy
1,253,787
+45,626
+4% +$820K ﹤0.01% 2567
2020
Q3 		$21.7M Sell
1,208,161
-149,231
-11% -$2.57M ﹤0.01% 2417
2020
Q2 		$22.4M Buy
1,357,392
+590,536
+77% +$9.29M ﹤0.01% 2363
2020
Q1 		$9.91M Sell
766,856
-101,830
-12% -$1.66M ﹤0.01% 2633
2019
Q4 		$16M Sell
868,686
-405,969
-32% -$6.73M ﹤0.01% 2636
2019
Q3 		$22.5M Buy
1,274,655
+109,828
+9% +$1.88M ﹤0.01% 2432
2019
Q2 		$19.5M Buy
1,164,827
+102,267
+10% +$1.86M ﹤0.01% 2523
2019
Q1 		$19.5M Buy
1,062,560
+97,380
+10% +$1.87M ﹤0.01% 2519
2018
Q4 		$19.2M Buy
965,180
+36,269
+4% +$679K ﹤0.01% 2461
2018
Q3 		$20.5M Buy
928,911
+602,710
+185% +$12.7M ﹤0.01% 2566
2018
Q2 		$8.44M Buy
+326,201
New +$5.59M ﹤0.01% 2986

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Group's ASTH Position: Q4 2025 in Review

Vanguard Group reduced its Astrana Health (ASTH) stake by 10% in Q4 2025, selling an estimated $12.8M and leaving 4,238,192 shares worth $105M. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Vanguard Group first reported a position in ASTH in Q2 2018 and has held it in 31 quarters since. The position peaked at $287M in Q3 2021. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Vanguard Group held 4,238,192 shares of Astrana Health worth $105M as of Q4 2025.
  • Vanguard Group sold 482,884 Astrana Health shares in Q4 2025, an estimated $12.8M.
  • Astrana Health made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1851 holding.
  • Vanguard Group first reported a position in Astrana Health in Q2 2018 and has held it in 31 quarters since.
  • Vanguard Group's Astrana Health position peaked at $287M in Q3 2021.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.